Stock DNA
Pharmaceuticals & Biotechnology
CNY 16,003 Million (Large Cap)
10.00
NA
3.77%
-0.29
11.77%
0.89
Revenue and Profits:
Net Sales:
13,087 Million
(Quarterly Results - Dec 2025)
Net Profit:
534 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-2.84%
0%
-2.84%
6 Months
-3.61%
0%
-3.61%
1 Year
-7.06%
0%
-7.06%
2 Years
-10.49%
0%
-10.49%
3 Years
-18.45%
0%
-18.45%
4 Years
1.01%
0%
1.01%
5 Years
-17.71%
0%
-17.71%
China National Medicines Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
4.83%
EBIT Growth (5y)
1.81%
EBIT to Interest (avg)
60.23
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.31
Sales to Capital Employed (avg)
2.60
Tax Ratio
24.71%
Dividend Payout Ratio
30.18%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
22.18%
ROE (avg)
14.07%
Valuation key factors
Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
1.24
EV to EBIT
8.43
EV to EBITDA
7.49
EV to Capital Employed
1.33
EV to Sales
0.33
PEG Ratio
NA
Dividend Yield
2.78%
ROCE (Latest)
15.83%
ROE (Latest)
11.85%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
13,087.00
13,747.40
-4.80%
Operating Profit (PBDIT) excl Other Income
602.40
623.20
-3.34%
Interest
7.00
5.20
34.62%
Exceptional Items
0.10
0.00
Consolidate Net Profit
533.50
564.40
-5.47%
Operating Profit Margin (Excl OI)
41.40%
40.90%
0.05%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is -4.80% vs 6.40% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is -5.47% vs 11.45% in Sep 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
52,362.30
50,498.60
3.69%
Operating Profit (PBDIT) excl Other Income
2,272.30
2,352.80
-3.42%
Interest
32.20
48.00
-32.92%
Exceptional Items
6.20
-17.50
135.43%
Consolidate Net Profit
2,089.40
2,129.80
-1.90%
Operating Profit Margin (Excl OI)
38.70%
41.70%
-0.30%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 3.69% vs 1.79% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -1.90% vs -8.77% in Dec 2024
About China National Medicines Co., Ltd. 
China National Medicines Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






